FactSet
FDS
$231.74
+10.97%
FactSet Research Systems (FactSet) is a leading provider of integrated financial data, analytics, and workflow solutions to the global investment community, operating within the Financial Data & Stock Exchanges industry. The company is a well-established, high-touch platform serving primarily buy-side clients, distinguishing itself through deep integrations and essential portfolio analytics that create a sticky user base. The current investor narrative is dominated by a significant valuation derating and concerns over competitive pressures, particularly from AI-driven disruption and potential market share loss to larger, more technologically aggressive rivals, as evidenced by the stock's precipitous ~48% decline over the past year and recent analyst downgrades highlighting structural challenges.…
FDS
FactSet
$231.74
Related headlines
Investment Opinion: Should I buy FDS Today?
Rating & Thesis: Hold. FactSet is a fundamentally strong company caught in a severe valuation derating due to legitimate fears about its long-term growth trajectory in the face of AI disruption; investors should wait for evidence of stabilization before committing new capital. This aligns with the cautious 'Underweight' and 'Sell' ratings prevalent among covering analysts.
Supporting Evidence: The stock trades at a forward P/E of 11.4x, which is deeply discounted relative to its history and suggests low growth expectations. However, revenue growth has decelerated to 7.1% YoY, and the price-to-sales ratio of 6.1x is not cheap for this growth rate. Positively, profitability remains stellar with a 25.7% net margin and strong free cash flow generation of $682.9M TTM. The lack of a clear consensus price target from analysts underscores the high uncertainty and wide dispersion of potential outcomes.
Risks & Conditions: The two biggest risks are sustained market share loss to AI-driven competitors and a further deceleration in revenue growth below 5%. This Hold rating would upgrade to a Buy if the forward P/E compressed further to near 10x while quarterly revenue growth stabilizes or re-accelerates above 8%. It would downgrade to a Sell if revenue growth falls below 5% or gross margins deteriorate below 50%. Relative to its own history, the stock is undervalued, but relative to its new, uncertain growth profile, it is likely fairly valued to slightly overvalued, awaiting clarity on the competitive front.
Sign up to view all
FDS 12-Month Price Forecast
The AI assessment is neutral with medium confidence. The valuation is compelling for a profitable cash-generator, but the growth trajectory is under a legitimate cloud. The stock is in a 'show me' state; the burden of proof is on management to demonstrate that the business model is not being disrupted. The stance would turn bullish on evidence of growth stabilization (quarterly revenue growth holding above 7%) and bearish on confirmation of market share loss (growth falling below 5%). The base case of range-bound trading is the most probable outcome over the next 12 months as this narrative plays out.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on FactSet's 12-month outlook, with a consensus price target around $301.26 and implied upside of +30.0% versus the current price.
Average Target
$301.26
6 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
6
covering this stock
Price Range
$185 - $301
Analyst target range
Analyst coverage appears limited, with only 6 analysts providing estimates, and the available data shows a consensus leaning bearish, as evidenced by recent institutional ratings from firms like Wells Fargo (Underweight), Barclays (Underweight), and Goldman Sachs (Sell). The consensus average target price is not explicitly provided in the data, but the recent price action and ratings suggest the implied upside may be constrained or negative. The target price range is also not available in the provided data, but the recent downgrades and 'Underweight'/'Sell' ratings indicate the low end of any target range would likely be below the current price, factoring in concerns over competitive displacement and growth deceleration. The pattern of recent analyst actions, with multiple firms reiterating or initiating Underweight/Sector Perform ratings in Q1 2026, signals a lack of near-term catalysts and a cautious stance on the stock's ability to regain its former growth trajectory, contributing to the high uncertainty and wide potential target dispersion.
Bulls vs Bears: FDS Investment Factors
The evidence currently favors the bear case, as reflected in the stock's catastrophic 48% decline, decelerating revenue growth, and overwhelmingly negative analyst sentiment centered on existential competitive threats. However, the bull case is supported by a compelling valuation reset to a forward P/E of 11.4x and the company's enduringly strong profitability and cash generation. The single most important tension in the investment debate is whether FactSet's high-touch, sticky platform and robust margins can defend its franchise against AI-driven disruption, or if it faces a permanent erosion of its growth profile and valuation. The resolution of this competitive threat will determine if the current price represents a deep-value opportunity or a value trap.
Bullish
- Deep Valuation Discount: The stock trades at a forward P/E of 11.4x, a significant discount to its trailing P/E of 23.7x and its historical valuation peaks above 30x. This forward multiple suggests the market has priced in severe pessimism, offering a potential margin of safety if earnings stabilize.
- Strong Profitability & Cash Flow: FactSet maintains robust profitability with a net margin of 25.7% and generates substantial free cash flow ($682.9M TTM). This financial strength provides a cushion for dividends, buybacks, and strategic investments to counter competitive threats.
- Healthy Balance Sheet: With a debt-to-equity ratio of 0.71 and a current ratio of 1.40, the company has a manageable leverage profile and ample liquidity. This reduces financial risk and provides flexibility during a period of market uncertainty.
- Oversold Technical Condition: The stock is down 47.9% over the past year and trades just 11% above its 52-week low of $185, indicating deeply oversold conditions. The low beta of 0.707 suggests this decline is company-specific, not market-driven, which could lead to a sharp rebound on any positive catalyst.
Bearish
- Severe Competitive & AI Disruption: The core investment narrative is dominated by fears of AI-driven disruption and market share loss to larger rivals. Recent analyst downgrades (Wells Fargo Underweight, Goldman Sachs Sell) explicitly cite these structural challenges, creating a significant overhang on the stock.
- Decelerating Revenue Growth: Recent quarterly revenue growth of 7.1% YoY shows a deceleration from prior periods. In a sector where growth commands premium valuations, this slowdown is a key driver behind the stock's 48% derating over the past year.
- Negative Analyst Sentiment & Momentum: Analyst consensus is bearish, with multiple recent 'Underweight' and 'Sell' ratings. The stock's relative strength of -72.93 over one year and a -28.8% drop in the past month confirm severe negative momentum and a lack of near-term catalysts.
- Valuation Compression Risk: Despite the recent drop, the stock's P/S ratio of 6.1x and P/B ratio of 6.5x remain elevated for a company with single-digit growth. If growth continues to slow, these multiples could compress further, limiting upside even if earnings meet expectations.
FDS Technical Analysis
The stock is in a pronounced and sustained downtrend, having lost 47.94% over the past year, significantly underperforming the S&P 500, which gained 24.99% over the same period. With a current price of $221.29, the stock is trading near the lower end of its 52-week range of $185 to $453.41, positioning it at approximately 11% above its 52-week low, which suggests it is deeply oversold and may present a potential value opportunity, though it remains firmly in a bearish phase. Recent momentum shows a slight divergence, with a 5.74% gain over the last three months, indicating a potential stabilization or short-term relief rally after the severe decline; however, this is contrasted by a -28.84% drop over the past month, signaling that selling pressure resumed recently. The stock's beta of 0.707 indicates it is about 30% less volatile than the broader market, which is notable given its dramatic price decline, suggesting the move is driven by company-specific fundamental concerns rather than broad market beta. Key technical support is clearly defined at the 52-week low of $185, while resistance sits at the 52-week high of $453.41. A breakdown below $185 would signal a continuation of the bearish trend, while a sustained move above the recent recovery highs near $270-$290 would be needed to suggest a more durable bottom is in place. The stock's relative strength metrics are deeply negative, with a -72.93 relative strength over one year, underscoring its severe underperformance.
Beta
0.71
0.71x market volatility
Max Drawdown
-59.2%
Largest decline past year
52-Week Range
$185-$453
Price range past year
Annual Return
-47.0%
Cumulative gain past year
| Period | FDS Return | S&P 500 |
|---|---|---|
| 1m | -1.7% | -2.9% |
| 3m | +16.8% | +15.0% |
| 6m | -20.7% | +5.6% |
| 1y | -47.0% | +19.1% |
| ytd | -18.7% | +6.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
FDS Fundamental Analysis
Revenue growth remains positive but modest, with the most recent quarterly revenue of $611.02 million representing a 7.07% year-over-year increase; however, this growth rate has decelerated from the high-single-digit/low-double-digit pace seen in prior quarters, indicating potential top-line pressure. The Americas segment, generating $396.18 million, is the dominant revenue driver, while the EMEA and Asia Pacific segments contribute $149.52 million and $61.93 million respectively, highlighting the company's reliance on the North American market. The company is consistently profitable, with net income of $133.06 million in the latest quarter and a trailing twelve-month net margin of 25.72%, demonstrating strong underlying profitability. Gross margin for the quarter was 51.43%, slightly down from 52.62% in the prior quarter, indicating some potential cost pressure or mix shift, while the operating margin of 30.27% remains robust for a financial data services firm. The balance sheet is healthy with a current ratio of 1.40 and a debt-to-equity ratio of 0.71, indicating manageable leverage. The company generates substantial free cash flow, with TTM free cash flow of $682.87 million, providing ample liquidity for dividends, share repurchases, and strategic investments, though recent cash flow statements show significant stock repurchase activity ($163.03 million in Q2 FY26) and dividend payments.
Quarterly Revenue
$611019000.0B
2026-02
Revenue YoY Growth
+0.07%
YoY Comparison
Gross Margin
+0.51%
Latest Quarter
Free Cash Flow
$682865000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is FDS Overvalued?
Given the company's consistent profitability with a net margin of 25.72%, the primary valuation metric is the P/E ratio. The trailing P/E stands at 23.71x, while the forward P/E is significantly lower at 11.41x, indicating the market expects a substantial recovery in earnings or has priced in a significant discount due to growth concerns. Compared to industry averages, the trailing P/E of 23.71x is likely at a premium to the broader financial data sector, though specific industry average data is not provided; the forward P/E of 11.41x suggests the premium may compress if forward estimates are met. Historically, the stock's own valuation has contracted dramatically from its recent peaks; for instance, its P/E ratio was above 30x in early 2025 and has now fallen to the low 20s, trading near the lower end of its multi-year historical range, which suggests the market has already priced in significant pessimism regarding future growth prospects. The price-to-sales ratio of 6.10x and price-to-book ratio of 6.48x further reflect a valuation reset from previous highs.
PE
23.7x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 15x~64x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
15.9x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: The primary financial risk is not leverage or liquidity—the balance sheet is sound—but rather revenue concentration and margin pressure. Over 64% of revenue comes from the Americas segment, creating geographic concentration. Furthermore, the quarterly gross margin dipped from 52.6% to 51.4%, signaling potential cost pressure or a less favorable revenue mix. The core risk is that modest 7% revenue growth fails to justify the current valuation multiples, leading to further compression. The company's substantial share repurchases ($163M in Q2) during the decline highlight a commitment to supporting the stock but could be value-destructive if the business fundamentals continue to weaken.
Market & Competitive Risks: The dominant external risk is competitive displacement, specifically from larger, more technologically aggressive rivals leveraging AI. This 'AI-phobia' has already hammered the software sector, as noted in recent news, and FactSet appears to be a prime target. The stock's low beta of 0.707 indicates the crash is company-specific, driven by this fear rather than broad market moves. Regulatory or macro risks are secondary; the primary threat is that FactSet's integrated workflow solutions become perceived as legacy technology, triggering client attrition and sustained growth deceleration below 5%.
Worst-Case Scenario: The worst-case scenario involves a confirmed loss of competitive moat, where AI-native platforms begin taking meaningful market share, leading to client cancellations and a growth stall. This would trigger a cascade of analyst downgrades and multiple compression towards pure utility-like valuations. The realistic downside would be a retest and break below the 52-week low of $185, potentially trending towards the stock's maximum drawdown level of nearly -60%. From the current price of $221.29, this implies a further potential loss of 16-20% to the $185 support, and a catastrophic loss of over 35% in a full bear case realization.
FAQ
The key risks are, in order of severity: 1) Competitive/Disruption Risk: The paramount threat is loss of market share to AI-powered rivals, potentially making its offerings obsolete. 2) Growth Deceleration Risk: Revenue growth has slowed to 7.1% YoY; a further drop below 5% would crush the investment thesis. 3) Valuation Compression Risk: Even at depressed levels, the P/S of 6.1x could compress further if growth slows. 4) Sentiment Risk: With major analysts like Goldman Sachs rating it Sell, negative sentiment can perpetuate further selling regardless of fundamentals.
Our 12-month forecast outlines three scenarios. The Base Case (50% probability) sees the stock range-bound between $220 and $260 as competitive fears linger but strong cash flow provides support. The Bull Case (25% probability) targets $300-$350 if the company alleviates disruption fears and its P/E expands. The Bear Case (25% probability) sees a drop to $170-$185 if growth deteriorates and the stock breaks key support. The most likely outcome is the base case, predicated on the assumption that the company's deep client integrations and profitability prevent an immediate collapse, but also limit a rapid recovery.
FDS is relatively undervalued compared to its own historical trading range, where its P/E was consistently above 30x. Its current forward P/E of 11.4x represents a dramatic discount. However, valuation is relative to future growth. With revenue growth decelerating to 7.1%, the stock's price-to-sales ratio of 6.1x is not cheap. The market is valuing FDS as if its growth profile has been permanently impaired. Therefore, it is arguably fairly valued to slightly overvalued if the low-growth scenario persists, but deeply undervalued if the company can defend its franchise and re-accelerate growth.
FDS is a high-risk, high-potential-reward stock at current levels, but it is not a clear-cut 'good buy' for most investors. The forward P/E of 11.4x is very attractive for a company with 25%+ net margins, implying significant upside if growth stabilizes. However, the severe 48% decline and bearish analyst sentiment are driven by real fears of AI-driven competitive disruption. It could be a good buy for deep-value, contrarian investors willing to accept the risk of permanent impairment, but it requires a long time horizon and a strong stomach for volatility. Conservative investors should wait for evidence of a fundamental turnaround.
FDS is unsuitable for short-term trading due to its low beta (0.707) and lack of positive near-term catalysts; it is mired in a negative narrative that could take quarters to resolve. It is primarily a long-term, contrarian investment for investors with a 3-5 year horizon who believe the competitive threat is overblown and that the company's cash flows will ultimately justify a higher valuation. The modest 1.1% dividend yield adds a small income component for long-term holders. A minimum holding period of 18-24 months is suggested to allow for the current investment thesis to play out.